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Uropathogenic strains of Escherichia coli bearing mannose-sensitive (type 1) fimbriae promote a unique
pattern of degranulation from human polymorphonuclear leukocytes (PMN). Significant quantities of the
primary (10) and tertiary (30) granule markers, neutral protease-myeloperoxidase and N-acetyl-o-D-glucosa-
minidase, respectively, were released by PMN in a dose- and time-dependent manner when stimulated by these
defined bacterial strains. Organisms bearing mannose-resistant (P) fimbriae promoted release of only the
secondary (2°) granule marker, vitamin B12-binding protein. When this pattern of degranulation was compared
to that produced by PMN in response to a variety of soluble and particulate stimuli, only the calcium ionophore
A23187 similarly triggered 1° and 30 granule marker release. All the other stimuli tested-zymosan,
serum-treated and unopsonized; n-formylmethionyl-leucyl-phenylalanine; and phorbol myristate acetate-
promoted release of only the 2° granule marker. These results demonstrate selectivity of PMN degranulation
in response to a number of transmembrane signals. In addition, the capacity of E. coli to promote PMN
degranulation is dependent on its phenotypic fimbrial expression, a surface characteristic which correlates
significantly with its relative surface hydrophobicity as measured by binding to octyl Sepharose. Those bacteria
demonstrating the greatest hydrophobicity were capable of triggering discharge of all three granule marker
proteins. Thus, the mannose-sensitive fimbriae of uropathogenic E. coli may contribute significantly to their
potential pathophysiologic role in renal scarring.
Chronic pyelonephritis is characterized by progressive
renal scarring. Recent evidence obtained by using animal
models has demonstrated that this scarring is directly pro-
portional to the magnitude of the initial inflammatory re-
sponse, which in turn is dependent on the interaction of
invading bacteria with host inflammatory cells (15, 34, 36).
Escherichia coli strains isolated from patients with urinary
tract infections possess a higher frequency of defined viru-
lence markers than do strains which compose the normal
fecal flora. These urinary tract pathogens express a re-
stricted range of 0 serotypes (30), resist the killing effects of
serum (20), and may elaborate alpha-hemolysin (6). After
isolation and subculture, these organisms usually express
surface fimbriae. Type 1, mannose-sensitive (MS) fimbriae
promote the mannose-dependent hemagglutination of guinea
pig erythrocytes (27, 37), whereas mannose-resistant (MR)
fimbriae, of which P fimbriae are a subgroup (41), promote
the mannose-independent hemagglutination of human eryth-
rocytes. Although both fimbrial types increase adherence to
uroepithelial cells (7, 22), type 1 (MS) fimbriae also mediate
adherence to and phagocytosis by human neutrophils (polyr-
morphonuclear leukocytes [PMN]) (4), and there is a direct
and highly significant correlation between the possession of
type 1 (MS) fimbriae, relative bacterial surface hydrophobic-
ity, and the capacity of the organism to activate the PMN
respiratory burst (19).
The activation of phagocytic cells by particulate stimuli
occurs as a result of either specific receptor-ligand binding
* Corresponding author.
t Present address: I.C.I. Diagnostics Group, Gadbrook Park,
Rudheath, Northwick, Cheshire, United Kingdom.
(26) or a receptor-independent physicochemical interaction
of a particle with the cell surface (42). This stimulus-cell
interaction has been characterized in terms of respiratory
burst activation (18), the release of intracellular proteins (3),
and the generation of pro-inflammatory mediators (44).
There is considerable evidence that the reactive oxygen
metabolites and proteases released by phagocytic cells dur-
ing this inflammatory response can contribute directly to
tissue damage (13, 14, 23). The human PMN has a well-
defined population of intracellular enzymes which are re-
leased from at least two distinct classes of cytoplasmic
granule in response to particulate or soluble stimuli (3, 35).
The primary (10) (azurophil) granule contains a number of
acid hydrolases and neutral proteases (such as elastase), as
well as myeloperoxidase (MPO). These enzymes are dis-
charged into the phagocytic vacuole and are believed to be
responsible for microbial killing through the action of the
various proteases and by the generation of hydrogen perox-
ide and toxic oxygen radicals (14). The secondary (2°)
(specific) granule contains a number of proteins, which
include lysozyme, lactoferrin, and vitamin B12-binding pro-
teins, as well as neutral proteases such as collagenase. Few
of these molecules have any defined antimicrobial activity,
but they may be secreted and function extracellularly to limit
chemotaxis and increase PMN adhesiveness (16, 31). Iso-
lated 20 granule protein release has been demonstrated after
activation of cells by a variety of ligands (35), emphasizing
the nonspecific, secretory nature of 20 granule release. A
peroxidase-negative tertiary (30) granule containing N-
acetyl-,3-D-glucosaminidase, P-galactosidase, and P-glucuro-
nidase has also been described (35), but its function has not
been defined in detail. Few studies have analyzed the degree
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of participation of each granule during degranulation in
response to either phagocytic or chemical stimulation (3, 32,
46).
The present study investigates the capacity of unopso-
nized uropathogenic strains of E. coli to trigger PMN degra-
nulation and correlates this capacity with the phenotypic
expression of fimbrial type. In addition, the unique pattern of
degranulation induced by certain of these strains of E. coli is
compared with the pattern of degranulation produced by
PMN stimulated with a variety of reference compounds.
MATERIALS AND METHODS
Preparation of human neutrophils. Normal human leuko-
cytes were isolated from citrated peripheral blood by dex-
tran sedimentation and were rendered plasma-free and plate-
let-poor by being washed with phosphate-buffered saline
without calcium or magnesium, pH 7.3. PMN were purified
by density gradient centrifugation at 400 x g for 35 min at
23°C on Ficoll-Paque (Pharmacia Ltd., Milton Keynes,
United Kingdom). The PMN were counted in a modified
Neubauer counting chamber after hypotonic lysis of the
erythrocytes. The cell preparations were judged to be 98%
PMN on the basis of their morphology after examination of
Wright-stained centrifuged preparations (Cytospin II; Shan-
don Southern Products, Runcorn, Cheshire, United King-
dom).
Preparation of reference stimuli. Unless stated otherwise,
all chemicals were purchased from Sigma Chemical Co.
Ltd., Poole, Dorset, United Kingdom. The calcium iono-
phore A23187 (Cambridge Bioscience, Cambridge, United
Kingdom), n-formylmethionyl-leucyl-phenylalanine, and
phorbol myristate acetate (PMA) were stored at 10 mM
concentrations in dimethyl sulfoxide at -70°C and diluted to
an appropriate concentration in Krebs Ringer phosphate
buffer (pH 7.4) containing 0.54 mM Ca2", 1.2 mM Mg2", and
11.0 mM D-glucose (KRPG) immediately before use. Zymo-
san A (500 mg) was boiled for 20 min in 50 ml of 0.9% saline,
washed, and resuspended to a final concentration of 10
mg/ml (5 x 108 particles per ml). Serum-treated zymosan
was prepared by suspending 20 mg of boiled zymosan in 1 ml
of KRPG, adding 3 ml of fresh pooled human serum, and
incubating this mixture with continuous mixing for 30 min at
37°C. The serum-treated zymosan was then washed three
times, suspended to a volume of 4 ml in KRPG, and stored
at -200C.
Bacterial strains. Eleven uropathogenic isolates of E. coli
were studied. Each was serially subcultured for 18 h either in
nutrient broth (Oxoid No. 2) or on nutrient agar (Oxoid Ltd.,
Basingstoke, United Kingdom) at least three times to facil-
itate the maximal expression of a required fimbrial type.
Bacteria were harvested by centrifugation, washed twice,
and suspended to an optical density of 2.0 at 560 nm in a
spectrophotometer (Unicam SP500 series 2; Pye Unicam,
Cambridge, United Kingdom) phosphate-buffered saline, pH
7.3 (equivalent to 109 CFU/ml).
The hemagglutination of guinea pig or human erythrocytes
by each bacterial strain was tested immediately prior to their
use in order to assess their fimbrial expression (Table 1).
Fimbriation was confirmed by transmission electron micros-
copy (17).
Bacterial phagocytosis. Purified human PMN were washed
and resuspended in RPMI 1640 (GIBCO Ltd., Paisley,
Scotland) containing 0.2% (wt/vol) bovine serum albumin at
a concentration of 3 x 106 cells per ml. One-milliliter
portions of the suspension were layered onto 35-mm tissue
culture plates, incubated at 37°C in 5% CO2 for 30 min, and
then washed three times with 2 ml of RPMI 1640 (containing
5 mM MgCl2). More than 97% of the adherent cells were
identified as PMN on the basis of their morphology.
The PMN monolayers were then incubated for 20 min with
different strains of E. coli suspended to a concentration of 4
x 108 bacteria per ml in RPMI 1640 containing MgCl2. The
monolayers were then washed three times with phosphate-
buffered saline (pH 7.3), air dried, fixed, and stained with
Wright's stain. The percentage of cells ingesting five or more
bacteria was estimated by light microscopy. At least 200
PMN per plate were counted.
Measurement of bacterial hydrophobicity. Bacterial sur-
face hydrophobicity was assessed by modified hydrophobic
interaction chromatography (N. Topley, R. Steadman, R. K.
Mackenzie, J. D. Williams, M. Davies, and A. W. Asscher,
Rev. Infect. Dis., in press). Briefly, Octyl Sepharose CL4B
columns (15 by 5 mm) (Pharmacia) were prepared, equili-
brated with 15 volumes of 0.25 M ammonium sulfate in 10
mM sodium phosphate buffer, pH 6.8 (ASP buffer), and
stored at 4°C until required. Samples of bacteria (optical
density at 560 nm = 1.0) (100 ,ul) were diluted 1:10 in ASP
buffer, and 500 ,ul of this dilution was loaded onto the column
and eluted with 2 ml of ASP buffer. Bacterial ATP was
extracted from eluted and from control bacterial suspensions
and measured by using the firefly bioluminescence assay
system (Topley et al., in press) in a Lumac M2010 bio-
counter (Lumac/3MbV, Schaesberg, The Netherlands). The
degree of binding of bacteria to the Octyl Sepharose was
then calculated and expressed as percent hydrophobicity.
Protein release experiments. One hundred-microliter vol-
umes of KRPG containing 5 x 105 PMN were diluted with
300 pl of KRPG and preincubated for 5 min at 37°C before
the addition of stimulus in KRPG (100 ,ul). Triplicate samples
were incubated with 100 ,ul of each stimulus at the appropri-
ate concentration for periods of up to 60 min and separated
by centrifugation for 1 min at 11,000 x g in a Beckman
Microfuge B (Beckman RIIC Ltd., High Wycombe, Buck-
TABLE 1. Surface characteristics of individual E. coli strains
Phenotypic BidnE. coli 0 hemagglutinationn P-fimbrial toBinding
strain serotype" expression' to dotl
MS MR Sepharose
504 06 +++ - - 76.8 ± 4.5
12 04 +++ - - 71.1 ± 3.5
ER2 04 - ++ + 33.8 ± 8.6
KV NT ++ - - 70.5 ± 3.4
AB NT - - - 28.8 ± 6.7
49 08 +++ - - 84.7 ±6.2
NK1 04 - ++ + 21.2 ± 8.2
SC 01 - ++ + 13.9 ± 6.1
168 04 +++ - - 84.6 ± 6.4
103 AA +++ - - N/A
63 NT - + + 6.8 ± 2.3
" Abbreviations: NT, not typable (smooth but not one of the following 0
serotypes: 1, 2, 4, 5, 6, 7, 8, 9, 11, 17, 18, 25, or 75); AA, autoagglutinable.b Hemagglutination of individual E. coli strains on the day of the experi-
ment. MS represents the capacity of D-mannose (2.5%, wt/vol) to inhibit the
agglutination of guinea pig erythrocytes by MS fimbriate organisms; MR
represents the mannose-resistant agglutination of human erythrocytes by MR
fimbriate organisms.
' P-fimbriation was assessed by the receptor-specific particle agglutination
test for E. coli (BACH-test, KabiVitrum, Stockholm, Sweden) of strains
grown on nutrient agar (39).
d Results are expressed as the means + standard deviations for at least
three separate determinations.
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inghamshire, United Kingdom), and the supernatant was
removed for the enzyme assays. Controls, which were
performed for each experiment, consisted of supernatant
from (i) unstimulated cells without incubation, (ii) cells
incubated in KRPG for periods of up to 60 min without
stimulation, (iii) stimuli incubated in KRPG without PMN,
and (iv) a KRPG blank incubated without PMN or stimulus.
Each stimulus was used in three separate experiments with
cells from three different donors.
Enzyme assays. The percent release of enzymes from the
PMN was calculated, after subtraction of the appropriate
blank values, as a percentage of that released from cells
disrupted by sonication, for two 1-min periods at an 8-p.m
peak-to-peak distance at 4°C in a 150-W ultrasonic disinte-
grator (Measuring and Scientific Equipment, Ltd., Crawley,
United Kingdom). This form of disruption gave reproducible
results for the maximal levels of total intracellular enzyme
activities measured when compared with freeze-thawing,
hypotonic lysis, and Triton X-100 extraction (data not
shown).
Control incubations. Granule marker release by PMN in
response to E. coli was compared in all cases with the
appropriate control cells incubated in buffer alone. There
was no detectable enzyme activity when E. coli strains were
incubated without PMN in KRPG for 60 min at 37°C.
In all experiments, <5% of the cytoplasmic marker lactic
dehydrogenase was released, indicating that most PMN
remained intact throughout the 60 min of stimulation.
MPO. One hundred microliters of supernatant from each
stimulation was incubated at 30°C with 1 ml of substrate
consisting of 0.3 mM o-dianisidine, 0.03% (vol/vol) H202,
and 0.05% (vol/vol) Triton X-100 (BDH Ltd., Poole, Dorset,
United Kingdom) in 0.1 M citric acid (pH 5.5). The reaction
was stopped after 5 min with 1 ml of 3.25 M perchloric acid.
The A560 was measured in a spectrophotometer (Cecil CE
292; Cecil Instruments Ltd., Cambridge, United Kingdom).
Neutral protease. Fifty microliters of supernatant was
added to 50 p.l (0.1 mg) of [3H]casein (0.41 ,uCi/mg) (21) in
phosphate buffer (pH 7.0) containing 1 mM CaC12 and
incubated for 16 h at 37°C. Ice-cold 11% (wt/vol) trichloro-
acetic acid (BDH Ltd.) was added. After incubation for 30
min at 4°C, the nonhydrolyzed casein was precipitated by
centrifugation at 11,000 x g for 5 min.
One hundred and seventy-five microliters of supernatant
containing the hydrolyzed product was then assayed for
released radioactivity by addition to 4 ml of scintillant
(Optiphase MP; LKB Instruments Ltd., Croydon, United
Kingdom) and counted in an LKB Rackbeta scintillation
counter for 1 min.
N-Acetyl p-D-glucosaminidase. One hundred microliters of
supernatant and 100 ,lI of substrate (0.2 mM 4-methylumbel-
liferyl N-acetyl f-D-glucosamine [Koch Light Ltd., Have-
hill, United Kingdom] in 0.1 M sodium citrate-phosphate
buffer, pH 4.3) were incubated for 16 h at 37°C. The reaction
was stopped by the addition of 2 ml of 5 mM EDTA (BDH
Ltd.) in 50 mM glycine buffer, pH 10.4. Fluorescence
emission at 448 nm was measured with excitation at 360 nm
in an Aminco Bowman spectrophotofluorimeter (American
Instrument Co. Inc., Silver Spring, Md.).
Vitamin B12-binding protein. One hundred microliters of
supernatant and 250 ,u1 of [57Co]cyanocobalamin (4.44 ng/ml
in water, 0.067 p.Ci/ml) (Amersham International plc, Car-
diff, United Kingdom) were incubated at room temperature
for 30 min. One milliliter of activated charcoal (Norit GSX;
BDH Ltd.) (5%, wt/vol) coated with 1% (wt/vol) bovine
serum albumin was added and left at room temperature for
10 min before centrifugation for 10 min at 2,500 x g to
precipitate charcoal-adsorbed, non-protein-bound vitamin
B12. One milliliter of supernatant was counted for 1 min in a
gamma counter (Kontron Instruments, St. Albans, United
Kingdom).
Lactate dehydrogenase. Three hundred microliters of su-
pernatant was added to 200 ,u1 of 10 mM ,-NADH in 2.4 ml
of 0.1 M phosphate buffer, pH 7.4. The reaction was started
with 100 ,ul of potassium pyruvate (1 mg/ml), and the change
in extinctions at 340 nm (E340) was measured over 4 min in a
Cecil CE292 spectrophotometer by using the reaction rate
calculator.
Gelatin-degrading activity. One hundred microliters of
supernatant was incubated at 37°C with 50 ,ul of 0.4 M Tris
hydrochloride, pH 7.5 (containing 10 mM CaCl2), and with
100 p.1 of [14C]gelatin (1 mg/ml, 0.045 ,uCi/mg) from dena-
tured interstitial rat skin collagen (95% type I, 5% type III)
(5). Fifty microliters of ice-cold 100% (wt/vol) trichloroacetic
acid was then added and incubated at 4°C for a further 30
min. The insoluble protein was pelleted in a Beckman
Microfuge at 11,000 x g for 10 min. One hundred and fifty
microliters of the supernatant was then dissolved in 4 ml of
Optiphase MP (LKB Ltd.) and counted in an LKB Rackbeta
scintillation counter for 1 min.
Elastase activity. One hundred microlite-rs of supernatant
was added to 100 ,ul of insoluble [3H]elastin (25 ,ug/ml; 0.05
,uCi/mg) (40) in 0.1 M Tris hydrochloride, pH 8.2, containing
0.1% (vol/vol) Triton X-100 and incubated at 40°C for 16 h.
Nondegraded elastin was precipitated by centrifugation in a
Beckman Microfuge at 11,000 x g for 10 min, and 100 p.l of
the supernatant was dissolved in 4 ml of Optiphase MP
scintillant and counted in an LKB Rackbeta scintillation
counter for 1 min.
Trasylol binding. Five hundred microliters of supernatant
from sonicated cells or from cells stimulated by E. coli 504
was mixed with 0.5 ml of 0.05 M Tris hydrochloride buffer,
pH 8.3, containing the serine protease inhibitor, Trasylol
(Bayer Pharmaceuticals Ltd., Haywards Heath, United
Kingdom), covalently bound to Sepharose beads (2). The
suspension was incubated with occasional mixing for 30 min
and then was centrifuged for 1 min at 11,000 x g. The
supernatant was assayed for activity against [3H]elastin.
After being washed in 0.05 M Tris hydrochloride buffer, pH
8.3, the pellet was suspended in 1 ml of 0.05 M sodium
acetate buffer, pH 5.0, and incubated at 4°C for 30 min. The
mixture was then centrifuged for 1 min at 11,000 x g, and the
activity against [3H]elastin released into the supernatant was
assayed.
Neutral protease inhibition. The serine protease inhibitor
phenylmethylsulfonyl fluoride (PMSF) was stored at 40C in
propan-2-ol at a concentration of 500 mM and was used in
the enzyme assays at a concentration of 5 mM. EDTA (100
mM) was used in the enzyme assays to inhibit metallopro-
teases at a concentration of 5 mM. p-Aminophenylmercuric
acetate (PAMA) was prepared to a concentration of 10 mM
in 0.05 M NaOH and used at 1 mM in the enzyme assays.
Statistics. All data in this paper was analyzed by using
Student's t test with Bessell's correction unless otherwise
stated in the text.
RESULTS
PMN granule marker release in response to bacterial stim-
ulation. Stimulation of 5 x 105 human PMN by 10 different
strains of E. coli of defined fimbrial type (Table 1) resulted in
the release of granule marker enzymes in a dose- (Fig. 1) and
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FIG. 1. Dose-dependent effect of E. coli on the capacity of 5 x
105 human PMN to release granule marker activity over a 60-min
period. Three representative strains of E. coli are shown: MS
fimbriate strain 504 (A), MR(P) fimbriate strain SC (B), and nonfim-
briate strain AB (C). Data are expressed as the means ± standard
deviations for three separate experiments with each strain using
PMN from different donors. Release of granule markers from
unstimulated cells was measured over a 60-min period (T60j.
marker proteins (10, t = 1.90, P < 0.05; 20, t = 5.68, P <
0.005; 30, t = 3.55, P < 0.05). Other compounds stimulated
significant release of only the 20 granule marker (Fig. 3).
Neutral protease release from human PMN. Type 1 (MS)
fimbriate E. coli 504 and the calcium ionophore A23187
caused significant release of proteolytic activity against
[3H]casein (P < 0.05), [3H]elastin (P < 0.05), and [14C]
gelatin (P < 0.02) (Fig. 4). All the other stimulants examined,
except the MR(P) fimbriate E. coli SC, caused release of
significant quantities of only [14C]gelatin-degrading activity.
This MR fimbriate organism caused release of significant
quantities of vitamin B12-binding protein alone (Fig. 1) in the
absence of release of gelatinase activity (Fig. 4).
The activity released against [3H]casein and [3H]elastin
from PMN stimulated with E. coli 504 or from sonicated
PMN was totally inhibited by 5 mM PMSF, a serine protease
inhibitor, but not by 5 mM EDTA, an inhibitor of metallo-
proteases (Fig. 5). Conversely, [14C]gelatin-degrading activ-
ity released by PMN was totally inhibited by 5 mM EDTA
but not by 5 mM PMSF. The inclusion of 1 mM PAMA
together with 5 mM PMSF did not increase the amount of
casein-, elastin-, or gelatin-degrading activity, indicating that
a metalloprotease with activity against these substrates was
not present in a latent form.
The release of a serine protease active against [3H]elastin
by PMN stimulated with E. coli 504 was confirmed by using
Trasylol covalently linked to Sepharose beads. In three
experiments, 95.5 ± 3% (mean ± standard deviation) of the
activity released from PMN stimulated by E. coli 504 was
bound to the Trasylol, of which 77 ± 12% was recovered by
elution with 0.05 M sodium acetate, pH 5.0. After sonication
of control cells, 93 ± 3% of the elastase activity was bound
by Trasylol, of which 97 ± 4% was recovered after elution at
pH 5.0.
Bacterial hydrophobicity. E. coli strains which demon-
time- (Fig. 2) dependent manner. Those strains possessing
type 1 (MS) fimbriae (n = 6) caused significant release of
marker enzymes from all three PMN granules (10 granule
marker, MPO [t = 9.4, P < 0.0005] and neutral protease
activity, measured as [3H]casein degradation (t = 12.0, P <
0.0005); 20 granule marker, vitamin B12-binding protein [t =
7.6, P < 0.0005]; 30 granule marker, N-acetyl P-D-glucosa-
minidase [t = 4.12, P < 0.001]). Those strains possessing
MR(P) fimbriae alone promoted significant release of only
the 20 granule marker (t = 1.88, P < 0.05, n = 4). MS
fimbriate strains caused significantly greater release of all
three granule markers compared with release by MR fim-
briate strains (10, t = 4.11, P < 0.005; 20, t = 2.45, P < 0.025;
309 t = 2.48, P < 0.025). Strains of E. coli bearing both type
1 (MS) and MR(P) fimbriae showed a pattern of release
identical to that of bacteria bearing type 1 (MS) fimbriae
alone (data not shown).
Bacterial phagocytosis by PMN monolayers. Five strains of
E. coli bearing type 1 (MS) fimbriae alone were phagocy-
tosed by between 33 and 100% in two separate experiments.
In contrast, four strains expressing MR(P) fimbriae alone
were phagocytosed by only 2 to 21% of PMN. One strain
expressing only type 1 (MS) fimbriae was not phagocytosed,
despite attachment, in either experiment.
PMN degranulation in response to stimulation with refer-
ence compounds. In a series of experiments under optimum
conditions of dose and time using a variety of particulate and
soluble compounds to stimulate PMN from several different
donors, only the calcium ionophore A23187 at concentra-
tions above 0.5 FxM caused significant release of all granule
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FIG. 5. Release of neutral protease activity (expressed as a
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[3H]casein, [3H]elastin, and [14C]gelatin) from 5 x 105 human PMN
after sonication (OI) and after 60 min of incubation with MS fimbriate
E. coli 504 (U). (A) Total enzymatic activity; (B) activity in the
presence of 5 mM EDTA; (C) enzymatic activity in the presence of
5 mM PMSF; (D) enzymatic activity in the presence of 5 mM PMSF
and 1 mM PAMA. Results expressed are the means ± standard
deviations for three experiments using PMN from different donors.
strated >50% binding to Octyl Sepharose columns (the most
hydrophobic strains) stimulated significantly greater release
of all the granule proteins than did those strains which bound
less avidly to the column (<50%) (MPO and caseinase, P <
0.005; vitamin B 2-binding protein, P < 0.05; N-acetyl
P-D-glucosaminidase, P < 0.005) (Fig. 6).
DISCUSSION
Human PMN challenged with defined strains of E. coli
released significant amounts of 10 (elastase and MPO) and 3°
(N-acetyl ,-D-glucosaminidase) granule marker proteins in a
time- and dose-dependent manner only when the strains
possessed surface MS (type 1) fimbriae. This pattern of
degranulation occurred whether these surface structures
were expressed alone or in conjunction with MR(P) fimbriae.
In contrast, those strains bearing MR(P) fimbriae alone did
not trigger significant release of 10 and 30 granule markers.
All strains examined, including nonfimbriate E. coli, stimu-
lated release of the 20 granule marker, vitamin B12-binding
protein.
When the pattern of degranulation initiated by type 1 (MS)
fimbriate strains was compared to that produced by PMN in
response to a variety of soluble and particulate stimuli, only
concentrations of the calcium ionophore A23187 above 0.5
,uM similarly triggered 10 and 30 granule marker release. All
the other stimuli tested triggered release of the 20 granule
marker, vitamin B12-binding protein, as well as gelatinase
activity. The variety of stimuli examined were selected for
their capacity to activate cells via a number of different
transmembrane signals. n-Formylmethionyl-leucyl-phenyl-
alanine and zymosan (either opsonized or unopsonized) are
known to interact with different receptors or recognition
mechanisms on the cell surface (28, 33, 45), and the chemo-
tactic tripeptide is a potent stimulus of phospholipase C (28).
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FIG. 6. Correlation of the release of granule marker activity from
5 x 105 human PMN with bacterial surface hydrophobicity ex-
pressed as percent binding to octyl Sepharose (HIC-BL). Each
datum point represents the mean of triplicate samples from three
separate experiments using PMN from different donors.
PMA directly activates membrane-bound protein kinase C
(8), and the calcium ionophore A23187 acts nonspecifically
by promoting the influx of calcium into the cell (12). These
soluble stimuli directly or indirectly affect the movement of
calcium into or within the cell, whereas zymosan has been
shown to induce a calcium-dependent response only when
opsonized with immunoglobulin G (25). All these stimuli
activate the PMN respiratory burst to various extents (18).
In terms of degranulation, however, only high concentra-
tions of A23187 were capable of mobilizing all the granule
markers measured, whereas at concentrations below 0.5 ,uM
only release of the 20 granule marker was detected. Thus,
even in the presence of receptor-ligand interaction or with
the activation of phospholipase C or of protein kinase C,
comprehensive degranulation does not necessarily occur,
emphasizing the unique nature of the activation of human
PMN by type 1 (MS) fimbriate E. coli strains.
In addition, the phagocytosis of E. coli strains expressing
type 1 (MS) fimbriae by PMN monolayers was significantly
greater than that of MR(P) fimbriate strains. However, a
single type 1 (MS) fimbriate organism consistently resisted
phagocytosis despite attachment to the PMN and caused a
degree of degranulation similar to that of the other type 1
(MS) fimbriate organisms studied. This finding, coupled with
the observation that phagocytosis of zymosan (whether
serum treated or unopsonized) results in the release of only
the 20 granule marker, indicates that comprehensive PMN
degranulation is not simply a response to phagocytosis per se
but occurs as the result of a specific surface interactioq with
the MS fimbriate organism.
Latent gelatinase activation could not be induced by
treatment with 1 mM PAMA, an organic mercurial com-
pound generally used to activate latent metalloproteases.
Although neutral proteases are distributed among several
intracellular compartments, activity against [3H]elastin is
confined to the specific serine protease (elastase) residing in
the 10 granule (11), whereas gelatin-degrading activity may
be located in a separate secretory compartment (10). By
selective inhibition of released proteases with PMSF and
EDTA and by their degree of binding to Trasylol (covalently
bound to Sepharose beads), the contribution of either serine
or metalloproteases to the total neutral protease activity
(measured as activity against [3H]casein) was estimated.
Caseinase activity was totally inhibited by PMSF and could
not be increased by treatment with PAMA, confirming that
most of the neutral protease activity released by the PMN
was due to serine proteases. Concomitant inhibition of
specific activity against [3H]elastin was also demonstrated
and confirmed the release of elastase, which could be bound
by Sepharose-bound Trasylol. The percentage of elastase
released correlated more closely with MPO release than did
total [3H]casein activity, confirming that activity against
[3H]elastin was a true marker of 10 granule release. All
stimuli tested, except the MR fimbriate E. coli SC, caused
release of gelatinase activity, which was inhibitable by
EDTA but not by PMSF, suggesting that a metalloprotease
was released independently of the 10 and 30 granules. This
protease was not released after stimulation by two other MR
fimbriate E. coli strains despite a significant release of
vitamin B 2-binding protein. This fact supports the hypoth-
esis that this enzyme may reside in a separate, as yet
undefined, secretory compartment (10).
The degranulation response of the PMN has been shown
in vitro to be capable of degrading a variety of biological
substrates (9, 24, 29) through the activity of the released
proteases. Of the enzymes released, the neutral serine
protease, elastase, is considered to be potentially the most
likely protease to cause in vivo tissue damage (8, 21, 29). In
the present study, we have demonstrated that PMN degra-
nulation stimulated by defined E. coli strains appears to be
dependent on the phenotypic fimbrial expression of the
stimulating strain, that phagocytosis is not essential for
extracellular marker enzyme release, and that there is a
significant correlation between relative bacterial surface
hydrophobicity and the pattern of PMN degranulation. We
have previously discussed the importance of possession of
MS fimbriae and increased relative surface hydrophobicity
as virulence factors in the initiation of renal scarring by E.
coli (Topley et al., in press). That possession of such
bacterial properties also causes a unique pattern of human
PMN degranulation, particularly of the potentially harmful
10 granule products, provides further evidence that MS
fimbriate E. coli may have a causative role in the initiation of
the tissue damage which precedes renal scarring.
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